EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Why Are Gonorrhea Case Rates Declining in the United States? A Research Agenda

Kirstin I Oliveira Roster iD, Peter J White iD, Yonatan H Grad iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf690 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Kirstin I Oliveira Roster und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston Massachusetts, USA. Hauptthemen laut MEDLINE: Gonorrhea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC HHS, UK Medical Research Council (MRC) Centre for Global Infectious Disease Analysis, Global Health EDCTP3 Joint Undertaking.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After nearly a decade of rising gonorrhea rates, the US Centers for Disease Control and Prevention (CDC) reported a decline in infection rates for 2 years in a row in 2022 and 2023, especially among young adults. While this warrants cautious optimism that control measures have been successful, the reasons for the decline are unknown. We do not know what lessons can be learned about the 4CMenB vaccine with partial protection against gonorrhea, doxycycline postexposure prophylaxis (doxy-PEP), asymptomatic screening, sexual behavior, or other possible drivers. Here, we enumerate potential drivers of the decline in gonorrhea, the evidence that argues for or against each one, and the data needed to clarify their roles. We hope to encourage those with suitable data to perform the analyses we outline, for surveillance systems to provide more detailed data where possible, and for existing and new surveillance and research studies to collect additional data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GonorrheaHumansUnited StatesCenters for Disease Control and Prevention, U.S.Post-Exposure ProphylaxisSexual BehaviorMass ScreeningDoxycycline

Stichwörter der Autor:innen

asymptomatic screeningdoxy-PEPgonorrheamenB vaccinesexual behavior

Substanzen

Doxycycline

Autor:innen und Institutionen

  • Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston Massachusetts, USA.
  • MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, and NIHR Health Protection Research Unit in Health Analytics & Modelling, Imperial College London, London, United Kingdom.
  • Modelling & Economics Unit, UK Health Security Agency, London, United Kingdom.

ORCID-Profile: Kirstin I Oliveira Roster, Peter J White, Yonatan H Grad

Förderung

  • CDC HHS
  • UK Medical Research Council (MRC) Centre for Global Infectious Disease Analysis
  • Global Health EDCTP3 Joint Undertaking
  • National Institute for Health and Care Research (NIHR) Health Protection Research Unit (HPRU) in Health Analytics and Modelling
  • UK Health Security Agency (UKHSA)
  • London School of Hygiene & Tropical Medicine (LSHTM)
  • Imperial College London
  • NIHR HPRU in Modelling and Health Economics

Zitieren

APA

Roster, K. I. O., White, P. J., & Grad, Y. H. (2026). Why Are Gonorrhea Case Rates Declining in the United States? A Research Agenda. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf690

Vancouver

Roster KIO, White PJ, Grad YH. Why Are Gonorrhea Case Rates Declining in the United States? A Research Agenda. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf690

BibTeX
@article{Roster2026,
  author = {Roster, Kirstin I Oliveira and White, Peter J and Grad, Yonatan H},
  title = {Why Are Gonorrhea Case Rates Declining in the United States? A Research Agenda},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf690}
}
Kostenlos starten →